Article
Current advances in cell therapy strategies for muscular dystrophies
10 Jan 2011
Abstract excerpt
INTRODUCTION: Muscular dystrophies are a heterogeneous group of genetic diseases characterized by muscle weakness, wasting and degeneration. Cell therapy consists of delivering myogenic precursor cells to damaged tissue for the complementation of missing proteins and/or the regeneration of new muscle fibres. AREAS COVERED: We focus on human candidate cells described so far (myoblasts, mesoangioblasts, pericytes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
